7 completed, 2 terminated, 1 active not recruiting, 1 withdrawn. 6 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Xoft, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite" Intra-operative Radiation Therapy - IORT - Invasive Ductal Carcinoma, Ductal Carcinoma In Situ | Not applicable | Withdrawn | Xoft, Inc. | 2022-06-30 | 2022-08-02 | |
| Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx Xoft eBx - Non-melanoma Skin Cancer | Completed | Xoft, Inc. | 183 | 2022-03-09 | 2025-01-13 | |
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab Radiation: Intra-operative Radiation Therapy - IORT, Bevacizumab - Glioblastoma, Recurrent Glioblastoma | Phase 2 | Terminated | Xoft, Inc. | 12 | 2021-11-02 | 2024-04-26 |
| Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study. Electronic Brachytherapy - Nonmelanoma Skin Cancer | Completed | Xoft, Inc. | 369 | 2016-10-01 | 2025-02-06 | |
| Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer Treatment with Electronic Brachytherapy - Cervical Cancer | Not applicable | Completed | Xoft, Inc. | 3 | 2013-11-01 | 2021-01-12 |
| Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® Intra-operative Radiation Therapy - IORT - Invasive Ductal Carcinoma, Ductal Carcinoma in Situ | Not applicable | Active not recruiting | Xoft, Inc. | 1200 | 2012-05-08 | 2025-01-31 |
| Electronic Brachytherapy for the Treatment of NMSC electronic brachytherapy - Basal Cell Carcinoma, Squamous Cell Carcinoma | Completed | Xoft, Inc. | 187 | 2009-08-01 | 2022-12-13 | |
| Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer brachytherapy, Xoft Axxent Electronic Brachytherapy System - Endometrial Cancer | Not applicable | Completed | Xoft, Inc. | 15 | 2008-10-01 | 2012-08-01 |
| Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer Intra-operative radiation therapy (IORT) - Breast Cancer | Not applicable | Terminated | Xoft, Inc. | 75 | 2008-09-01 | 2017-07-25 |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer Electronic Brachytherapy, Intracavitary accelerated partial breast irradiation - Breast Cancer, Carcinoma | Phase 4 | Completed | Xoft, Inc. | 63 | 2008-05-01 | 2016-05-17 |
| Post Market Study Using the Xoft Axxent System Electronic brachytherapy (Axxent System) - Breast Cancer | Not applicable | Completed | Xoft, Inc. | 44 | 2007-03-26 | 2020-08-13 |
Breast Neoplasms (3) · Carcinoma, Intraductal, Noninfiltrating (3) · Neoplasms (3) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Squamous Cell (1) · Endometrial Neoplasms (1) · Glioblastoma (1) · Uterine Cervical Neoplasms (1) · Uterine Neoplasms (1)
Brachytherapy (3) · Radiotherapy (2) · Therapeutics (2) · Bevacizumab (1) · Drug Delivery Systems (1) · Mohs Surgery (1) · Radiation (1)
United States (10) · Australia (1) · Portugal (1)
Adam Dickler, MD (2) · Rakesh Patel, MD (2) · A. M. Nisar Syed, MD (1) · A.M. Nisar Syed, MD (1) · Ajay Bhatnagar, MD, MBA (1) · Lowndes Harrison, MD (1) · Peter Beitsch, MD (1) · Robert Strimling (1) · Santosh Kesari, MD (1) · Stephen Doggett, MD (1) · Vivek K Mehta, MD (1)